ArticleGynecologic oncology2013
Bowel obstruction in elderly ovarian cancer patients: a population-based study.
Article in Gynecologic oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03260647 (Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction), which is not on this map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction (MAMBO) Program for Women With Advanced Gynecological Cancers
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.
- Non-Surgical Management of Malignant Bowel Obstruction in Advanced Ovarian Cancer patients: A Systematic Review and Meta-Analysis.The American journal of hospice & palliative care · 2022Pooled it
- Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.The Cochrane database of systematic reviews · 2016Pooled it
- Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery.World journal of surgical oncology · 2025Article
- Self-expanding metallic stent insertion for malignant bowel obstruction secondary to gynecologic malignancies: a retrospective analysis : SEMS for gynecological MBO is efficient.Surgical endoscopy · 2025Article
- Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degradingFrontiers in immunology · 2025Article
- A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery?Gynecologic oncology · 2024Article
- Management of Malignant Bowel Obstruction in Patients with Gynaecological Cancer: A Systematic Review.Journal of clinical medicine · 2024Review
- Metastatic Uterine Leiomyosarcoma presenting as small bowel intussusception at two independent visits.Gynecologic oncology reports · 2024Article
- Surgery for Recurrent Epithelial Ovarian Cancer.Current oncology reports · 2024Review
- Incidence of and survival after surgical intervention for bowel obstruction in women with advanced ovarian cancer.Acta obstetricia et gynecologica Scandinavica · 2023Article
- Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study.Annals of medicine and surgery (2012) · 2023Article
- Developing and Field Testing BOLSTER: A Nurse-Led Care Management Intervention to Support Patients and Caregivers following Hospitalization for Gynecologic Cancer-Associated Peritoneal Carcinomatosis.Journal of palliative medicine · 2022Article
- Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Superior Survival for Medicare Patients with Advanced Malignancy.Annals of surgical oncology · 2021Article
- Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists.Trauma surgery & acute care open · 2021Article
- Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.Journal of oncology practice · 2019Article
- The role of parenteral nutrition in patients with malignant bowel obstruction.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Review
- A nomogram for predicting bowel obstruction in preoperative colorectal cancer patients with clinical characteristics.World journal of surgical oncology · 2019Article
- Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management.BMC cancer · 2018Article
- Survival, Healthcare Utilization, and End-of-life Care Among Older Adults With Malignancy-associated Bowel Obstruction: Comparative Study of Surgery, Venting Gastrostomy, or Medical Management.Annals of surgery · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
purposeBowel obstruction is a common pre-terminal event in abdominal/pelvic cancer that has mainly been described in small single-institution studies. We used a large, population-based database to investigate the incidence, management, and outcomes of obstruction in ovarian cancer patients. PATIENTS AND
methodsWe identified patients with stages IC-IV ovarian cancer, aged 65 years or older, in the Surveillance, Epidemiology and End Results (SEER)-Medicare database diagnosed between January 1, 1991 and December 31, 2005. We modeled predictors of inpatient hospitalization for bowel obstruction after cancer diagnosis, categorized management of obstruction, and analyzed the associations between treatment for obstruction and outcomes.
resultsOf 8607 women with ovarian cancer, 1518 (17.6%) were hospitalized for obstruction subsequent to cancer diagnosis. Obstruction at cancer diagnosis (HR=2.17, 95%CI: 1.86-2.52) and mucinous tumor histology (HR=1.45, 95%CI: 1.15-1.83) were associated with increased risk of subsequent obstruction. Surgical management of obstruction was associated with lower 30-day mortality (13.4% in women managed surgically vs. 20.2% in women managed non-surgically), but equivalent survival after 30 days and equivalent rates of post-obstruction chemotherapy. Median post-obstruction survival was 382 days in women with obstructions of adhesive origin and 93 days in others.
conclusionIn this large-scale, population-based assessment of patients with advanced ovarian cancer, nearly 20% of women developed bowel obstruction after cancer diagnosis. While obstruction due to adhesions did not signal the end of life, all other obstructions were pre-terminal events for the majority of patients regardless of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.